MARÍA DOLORES
CABALLERO BARRIGÓN
Investigadora en el periodo 1998-2022
University Medical Center Freiburg
Friburgo de Brisgovia, AlemaniaPublicaciones en colaboración con investigadores/as de University Medical Center Freiburg (2)
2006
-
Piperacillin-tazobactam monotherapy in high-risk febrile and neutropenic cancer patients
Clinical Microbiology and Infection, Vol. 12, Núm. 3, pp. 212-216
2003
-
Long-term disease-free survival in patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation
Haematologica, Vol. 88, Núm. 11, pp. 1272-1278